|
1
|
Kobayashi E, Hornicek FJ and Duan Z:
MicroRNA involvement in osteosarcoma. Sarcoma. 2012:3597392012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Marina N, Gebhardt M, Teot L and Gorlick
R: Biology and therapeutic advances for pediatric osteosarcoma.
Oncologist. 9:422–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zamore PD and Haley B: Ribo-gnome: The big
world of small RNAs. Science. 309:1519–1524. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shin C, Nam JW, Farh KK, Chiang HR,
Shkumatava A and Bartel DP: Expanding the microRNA targeting code:
Functional sites with centered pairing. Mol Cell. 38:789–802. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qin S, Ai F, Ji WF, Rao W, Zhang HC and
Yao WJ: miR-19a promotes cell growth and tumorigenesis through
targeting SOCS1 in gastric cancer. Asian Pac J Cancer Prev.
14:835–840. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jones KB, Salah Z, Del Mare S, Galasso M,
Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, et
al: miRNA signatures associate with pathogenesis and progression of
osteosarcoma. Cancer Res. 72:1865–1877. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lam CS, Ng L, Chow AK, Wan TM, Yau S,
Cheng NS, Wong SK, Man JH, Lo OS, Foo DC, et al: Identification of
microRNA 885-5p as a novel regulator of tumor metastasis by
targeting CPEB2 in colorectal cancer. Oncotarget. 8:26858–26870.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoshino H, Yonemori M, Miyamoto K,
Tatarano S, Kofuji S, Nohata N, Nakagawa M and Enokida H:
microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis
through revival of TWIST1 in renal cell carcinoma. Oncotarget.
8:20881–20894. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Petric R, Gazic B, Goricar K, Dolzan V,
Dzodic R and Besic N: Expression of miRNA and occurrence of distant
metastases in patients with Hürthle cell carcinoma. Int J
Endocrinol. 2016:89452472016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Z, Yin J, Yang J, Shen W, Zhang C,
Mou W, Luo J, Yan H, Sun P, Luo Y, et al: miR-885-5p suppresses
hepatocellular carcinoma metastasis and inhibits Wnt/β-catenin
signaling pathway. Oncotarget. 7:75038–75051. 2016.PubMed/NCBI
|
|
15
|
Allen-Rhoades W, Kurenbekova L,
Satterfield L, Parikh N, Fuja D, Shuck RL, Rainusso N, Trucco M,
Barkauskas DA, Jo E, et al: Cross-species identification of a
plasma microRNA signature for detection, therapeutic monitoring,
and prognosis in osteosarcoma. Cancer Med. 4:977–988. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao G, Cai C, Yang T, Qiu X, Liao B, Li
W, Ji Z, Zhao J, Zhao H, Guo M, et al: MicroRNA-221 induces cell
survival and cisplatin resistance through PI3K/Akt pathway in human
osteosarcoma. PLoS One. 8:e539062013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi K, Lan RL, Tao X, Wu CY, Hong HF and
Lin JH: Vitronectin significantly influences prognosis in
osteosarcoma. Int J Clin Exp Pathol. 8:11364–11371. 2015.PubMed/NCBI
|
|
19
|
Enneking WF, Spanier SS and Goodman MA: A
system for the surgical staging of musculoskeletal sarcoma. Clin
Orthop Relat Res. 106–120. 1980.PubMed/NCBI
|
|
20
|
Han K, Zhao T, Chen X, Bian N, Yang T, Ma
Q, Cai C, Fan Q, Zhou Y and Ma B: microRNA-194 suppresses
osteosarcoma cell proliferation and metastasis in vitro and in vivo
by targeting CDH2 and IGF1R. Int J Oncol. 45:1437–1449. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Arndt CA, Rose PS, Folpe AL and Laack NN:
Common musculoskeletal tumors of childhood and adolescence. Mayo
Clin Proc. 87:475–487. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nelson KM and Weiss GJ: MicroRNAs and
cancer: Past, present, and potential future. Mol Cancer Ther.
7:3655–3660. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu SW, Li JP, Ma XL, Ma JX, Yang Y, Chen
Y and Liu W: miR-9 modulates osteosarcoma cell growth by targeting
the gcip tumor suppressor. Asian Pac J Cancer Prev. 16:4509–4513.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ziyan W, Shuhua Y, Xiufang W and Xiaoyun
L: MicroRNA-21 is involved in osteosarcoma cell invasion and
migration. Med Oncol. 28:1469–1474. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kawano M, Tanaka K, Itonaga I, Ikeda S,
Iwasaki T and Tsumura H: microRNA-93 promotes cell proliferation
via targeting of PTEN in Osteosarcoma cells. J Exp Clin Cancer Res.
34:762015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ma C, Zhan C, Yuan H, Cui Y and Zhang Z:
MicroRNA-603 functions as an oncogene by suppressing BRCC2 protein
translation in osteosarcoma. Oncol Rep. 35:3257–3264. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu JF, Yang GH, Pan XH, Zhang SJ, Zhao C,
Qiu BS, Gu HF, Hong JF, Cao L, Chen Y, et al: Altered microRNA
expression profile in exosomes during osteogenic differentiation of
human bone marrow-derived mesenchymal stem cells. PLoS One.
9:e1146272014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wagner ER, Luther G, Zhu G, Luo Q, Shi Q,
Kim SH, Gao JL, Huang E, Gao Y, Yang K, et al: Defective osteogenic
differentiation in the development of osteosarcoma. Sarcoma.
2011:3252382011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Carpten JD, Robbins CM, Villablanca A,
Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders
EM, Kennedy AM, Chen JD, et al: HRPT2, encoding parafibromin, is
mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet.
32:676–680. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shattuck TM, Välimäki S, Obara T, Gaz RD,
Clark OH, Shoback D, Wierman ME, Tojo K, Robbins CM, Carpten JD, et
al: Somatic and germ-line mutations of the HRPT2 gene in sporadic
parathyroid carcinoma. N Engl J Med. 349:1722–1729. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao J, Yart A, Frigerio S, Perren A,
Schraml P, Weisstanner C, Stallmach T, Krek W and Moch H: Sporadic
human renal tumors display frequent allelic imbalances and novel
mutations of the HRPT2 gene. Oncogene. 26:3440–3449. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang C, Kong D, Tan MH, Pappas DL Jr,
Wang PF, Chen J, Farber L, Zhang N, Koo HM, Weinreich M, et al:
Parafibromin inhibits cancer cell growth and causes G1 phase
arrest. Biochem Biophys Res Commun. 350:17–24. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
James RG, Biechele TL, Conrad WH, Camp ND,
Fass DM, Major MB, Sommer K, Yi X, Roberts BS, Cleary MA, et al:
Bruton's tyrosine kinase revealed as a negative regulator of
Wnt-beta-catenin signaling. Sci Signal. 2:ra252009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Selbach M, Schwanhäusser B, Thierfelder N,
Fang Z, Khanin R and Rajewsky N: Widespread changes in protein
synthesis induced by microRNAs. Nature. 455:58–63. 2008. View Article : Google Scholar : PubMed/NCBI
|
